NextCell Pharma AB's total assets for Q4 2025 were kr76.73M, an increase of 46.97% from the previous quarter. DE:65G total liabilities were kr10.34M for the fiscal quarter, a -6.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.